Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Rating of “Moderate Buy” by Analysts
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received an average rating of “Moderate Buy” from the twenty-two brokerages that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and eighteen have issued a buy recommendation on […]
6 Aug 06:29 · The Cerbat Gem